Statins for Graves' orbitopathy (STAGO): a phase 2, open-label, adaptive, single centre, randomised clinical trial - The Lancet Diabetes & Endocrinology

Long-term efficacy and safety of moderate-intensity statin with

Cholesterol Serum Levels and Use of Statins in Graves' Orbitopathy

Current concepts regarding Graves' orbitopathy - Bartalena - 2022

Statins for Graves' orbitopathy: a new tool for prevention and

Proposal for Standardization of Primary and Secondary Outcomes in

Statins and Risk of New-Onset Diabetes Mellitus

Current and Emerging Treatment Strategies for Graves' Orbitopathy

Current concepts regarding Graves' orbitopathy - Bartalena - 2022

PDF) Management of Thyroid Eye Disease: A Consensus Statement by

Statin Use Associated with Lower Incidence of Developing Thyroid

Management of Thyroid Eye Disease: A Consensus Statement by the

Full article: How can we prevent disease relapse in Graves

Management of Thyroid Eye Disease: A Consensus Statement by the

Statins and risk of incident diabetes: a collaborative meta